Federal Medical Centre, Yenagoa Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04539249
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Obstetrics and Gynaecology, Federal Medical Centre, Yenagoa | Federal Medical Centre, Yenagoa | Olakunle Ifeoluwa Makinde | OZORI EBIOGBO STANLEY

Active Ingredients

Drugs in Other Trials (2)

magnesium sulfate (Tis-U-Sol) (1 trial)

pentazocine (talwin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2